Drugs
Every drugs we track across medical research, 18 entries in all.
Heart Failure Drug Combo Effects Modeled
A pooled analysis of 38,753 patients from nine trials provides individualized estimates for how combinations of modern heart failure drugs affect...
Alnylam defends silencer drugs after
Alnylam defends its RNAi drugs after AstraZeneca's heart disease trial failure, arguing they work even for patients on stabilizer therapies.
Obesity Medicines Are Disruptive Innovation
A commentary in Nature Medicine argues that new anti-obesity drugs represent a disruptive innovation requiring health system adaptation, with the...
EPIDAURUS trial halted over bleeding risk
The EPIDAURUS trial testing potent antiplatelet drugs with anticoagulants in atrial fibrillation and acute coronary syndrome patients was stopped...
Novo Nordisk CEO Warns of Growing Competition in Obesity Drug Market
Novo Nordisk's CEO believes investors are underestimating the demand for differentiation among obesity drugs, and that new treatment options like...
FDA Approves Bristol Myers Squibb’s Zenbexus for Advanced Multiple Myeloma, Marking Debut of New Drug Class
The U.S. FDA has approved Zenbexus, Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of blood cancer...